Your session is about to expire
← Back to Search
Intervention Group for Osteoarthritis (KICK-OA Trial)
KICK-OA Trial Summary
This trial is testing whether an injection of autologous, nucleated cells can help improve symptoms for people with knee osteoarthritis.
- Osteoarthritis of the Knee
KICK-OA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.KICK-OA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To whom does this research opportunity apply?
"The ideal candidate for this knee clinical trial is aged 40-79. Out of the total 10 people that this study needs, how many will you be?"
Does this experiment only include patients that are over the age of seventy?
"This particular clinical trial is only looking for patients that are 40 to 79 years old. In contrast, there are 39 other trials underway for patients under 18 and 691 trials involving seniors."
Are investigators still searching for study participants?
"Although this specific study is not looking for any more participants, that doesn't mean there aren't other opportunities to get involved in medical research. According to clinicaltrials.gov, this trial was first posted on 1/1/2022 and updated as recently as 7/17/2021. There are presently 728 other trials recruiting patients."
Are there any dangers that come with Autologous Nucleated Cells treatments?
"Autologous Nucleated Cells have not yet been proven effective, but there is enough data supporting its safety to give it a score of 2."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger